| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |